Every merger & restructuring announcement on NSE and BSE that our alert engine sent, newest first. Each one has its own page with the summary, the key figures and the original filing.
Emcure Pharmaceuticals will acquire a 12.05% stake in Gennova Biopharmaceuticals for Rs. 231.87 Crore. This transaction will make Gennova a wholly-owned subsidiary by July 2026.
Somany Ceramics approved Rs. 75.80 Crore in total investments. This includes acquiring stakes in Siravit Ceramics, V.S. Industries Nepal, and increasing its holding in subsidiary SSCPL.
Creative Newtech announced a proposed acquisition of Infinova India, with a board‑approved budget of up to USD 4 million (≈₹38 Crore). The deal aims to build a Make‑in‑India surveillance technology platform.
Talbros Engineering Ltd entered an agreement to sell a 40,000 sq ft property to Lakhani Rubber Products for ₹25 crore. The transaction is disclosed under Regulation 30.
Tata Capital Ltd approved acquiring 88.6% of Yogakshemam Loans Ltd for ₹93 crore cash consideration. Completion is expected within eight months, expanding its gold loan portfolio.
TVS Supply Chain Solutions received NCLT Chennai approval for the amalgamation of five subsidiaries. The merger remains subject to final sanction from the NCLT Bengaluru Bench.
Arvaya Healthcare will acquire Sushodha Institute of Gastroenterology for Rs.15.49 Crore via share swap. The 100% stake acquisition expands its specialized healthcare footprint in India.
Anlon Healthcare incorporated a 65% subsidiary, Anlon Biologics Private Limited, for Rs. 0.065 Crore. The unit will manufacture surgical implants and biosimilars.
Standard Engineering Technology approved acquiring a controlling stake in GScale Energy via a share swap. The deal involves issuing shares worth Rs. 136.48 Crore.
Mankind Pharma will sell its subsidiary Broadway Hospitality Services to AKRK Projects for ₹49 Crore. The cash deal is expected to conclude by October 2026.
Mankind Pharma will incorporate a wholly-owned subsidiary in Netherlands with a 54 Crore investment. The entity will hold R&D assets and pursue niche therapy joint ventures.
Mankind Pharma approved divesting 100% stake in Broadway Hospitality for Rs. 49 Crore. It also plans to invest €5 Million to incorporate a new Netherlands-based subsidiary.
Elgi Equipments' US subsidiary divested its stake in PLA Holding Company for USD 100,000 (Rs.0.95 Crore). The transaction was completed on July 10, 2026.
Emcure's subsidiary, Gennova Biopharmaceuticals, will sell its mRNA business to Immunoscript Life Science for Rs. 139.5 Crore. The slump sale aligns with strategic business reorganization.
Triveni Engineering fixed July 22, 2026, as the record date for its demerger. Shareholders receive one TPTL share for every three shares held in the company.
Reliance Infrastructure subsidiary MMOPL signed a Rs.2,771.32 crore Master Restructuring Agreement with NARCL. This agreement facilitates debt restructuring and withdrawal of insolvency proceedings.
GMR Power subsidiary GKSPL allotted equity to Grasim Industries for a 10 MW solar project. GKSPL's status changed from wholly owned to step-down subsidiary.
NCLT approved a Rs. 203 Crore preference share capital reduction for subsidiary DEXIT Global. Proceeds will fund deferred payments to NSE for the prior acquisition.
PDS Limited completed the sale of its Sri Lankan subsidiary, Nobleswear (Private) Limited, for USD 1. The transaction involves a buyer named Nobles (Private) Limited.
Inventurus Knowledge Solutions subsidiary executed a subordination agreement to facilitate the $565 million acquisition of TruBridge. This arrangement supports $635 million in financing facilities.
PDS Limited subsidiary divested its 26% stake in Nobleswear (Private) Limited for Rs. 0.95 Crore. Consequently, Nobleswear ceases to be an associate company.
H.G. Infra Engineering incorporated H.G. Buildskills Private Limited as a wholly-owned subsidiary with Rs. 0.01 Crore initial capital. The unit focuses on training and consultancy.
CESC's subsidiary Purvah Green Power incorporated Purvah Sunrise Energy as a new renewable power subsidiary. The new entity has a paid-up capital of Rs. 0.01 Crore.
Dolphin Offshore incorporated a wholly-owned subsidiary, Beluga International, in GIFT City for ₹1.82 Crore. The new entity will focus on ship and ocean vessel leasing.
Ajmera Realty sold its entire 36% stake in associate Ultra Tech Property Developers for Rs. 1.73 Crore. The entity ceases to be an associate company effective July 2026.
Orchid Pharma announced that the merger of Dhanuka Laboratories Limited is now effective. Dhanuka Laboratories stands dissolved following the filing of NCLT orders with the ROC.
ALFA Finder